Clinical trial Recruiting at 1 site Observational Ages 18 and up

Investigating the gut microbiome's role in sepsis and brain function in critically ill patients

Official title: The Gut Microbiome - Source of Sepsis and Novel Target in Intensive Care Units? Research on Human Tissue, Body Fluids, Neuropsychological Assessment and Brain Imaging

Run by Jena University Hospital · NCT06749483 · Data updated 2026-11-12

This study is trying to see how changes in gut bacteria from antibiotic use affect brain function and recovery in critically ill patients with severe infections or sepsis.

More Sepsis trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorJena University Hospital
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Jena, Thuringia)
StatusRecruiting
StartedDecember 27, 2024
Main results expectedJune 30, 2026
Study endsDecember 31, 2026
Registry record updatedDecember 30, 2024
Trial IDNCT06749483 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include critically ill patients aged 18 and older receiving specific antibiotic treatments or those expected to stay in the ICU for more than three days.

Probably not a fit

Patients with inflammatory bowel disease, major bowel resection, or acute neurological diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore how reduced microbiome complexity, due to broad-spectrum antibiotic treatment, affects critically ill patients with severe infections or sepsis. Researchers will collect stool, rectal swab, and plasma samples, alongside clinical and neuropsychological data, to assess the relationship between microbiome dysbiosis and brain dysfunction. The study will also analyze immune cell diversity and investigate the impact of specific bacterial communities on patient outcomes over time. By correlating metagenomic and metabolomic data with clinical results, the study seeks to uncover new insights into the gut-brain axis in critically ill patients.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of sepsis-related brain dysfunction in critically ill patients.

How similar studies have gone: While the approach of linking microbiome analysis to brain function in critically ill patients is innovative, similar studies have shown promising results in understanding the gut-brain connection.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* One of the following criteria

  1. Critically ill patients treated with meropenem or piperacillin/tazobactam started within the last 72 h
  2. Critically ill patients without systemic antimicrobial therapy within the last 72 hours and an expected ICU length of stay of more than 3 days
  3. Long-term survivors of sepsis, e.g. from pre-existing sepsis cohorts

Exclusion Criteria:

* Inflammatory bowel disease
* Major bowel resection
* Selective decontamination of the oral and digestive tract
* Oral vancomycin therapy
* Immunocompromised patients
* History of chemotherapy during the last 6 months.
* Known travel history to countries to areas of high antimicrobial resistance (\>5% according to the report of the European Centre for Disease Prevention and Control and all countries except USA and Canada) within the last 4 weeks
* Acute neurological diseases (e.g., brain ischemia, hemorrhage, meningoencephalitis, tumor)
* Manifest dementia, pre-existing psychiatric diseases (schizophrenia, psychosis)
* Acute brain surgery
* MRI contraindications: pacemakers, hearing aids, neurostimulation, insulin pumps, other potentially ferromagnetic implants, screws, clips, prostheses, metal splinters, etc., pregnancy, claustrophobia, extensive tattoos.

Where it's running

  • Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Jena
    Jena, Thuringia, Germany
    Recruiting

Study contacts

  • Principal investigator: Johannes Ehler, Priv.-Doz. Dr. med. — Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital
  • Study coordinator: Johannes Ehler, Priv.-Doz. Dr. med.
  • Email: johannes.ehler@med.uni-jena.de
  • Phone: +49 36419323397

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.